iCAD to Report Fourth Quarter and Fiscal Year Ended December 31, 2018 Financial Results on Monday, March 18
NASHUA,
N.H. (March 13, 2019) – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing
innovative cancer detection and therapy solutions, today announced that it will release financial
results for the fourth quarter and fiscal year ended December 31, 2018, after
the close of the market and host a conference call at 4:30 pm Eastern Time on Monday,
March 18.
Monday, March 18, 2019, at 4:30 PM ET
Domestic: 877-407-0784
International: 201-689-8560
Conference
ID: 13687103
Webcast: http://public.viavid.com/index.php?id=133091
Replays available
through April 1st:
Domestic:
844-512-2921
International: 412-317-6671
Replay
PIN: 13687103
About iCAD, Inc.
Headquartered in Nashua, NH, iCAD is a
global medical technology leader providing innovative cancer detection and
therapy solutions. For more information, visit www.icadmed.com.
Contact:
Media
Inquiries:
ARPR,
on behalf of iCAD, Inc.
Paul Barren
(855) 300-8209
or
Investor
Relations:
LifeSci
Advisors
Jeremy
Feffer
(212)
915-2568